Total number of patients | 163 |
Gender | Female |
Age at diagnosis mean, (range) years | 63 (32 - 85) |
Histology, n (%) | |
Invasive ductal carcinoma | 129 (79%) |
Invasive lobular carcinoma | 23 (14%) |
Other | 11 (7%) |
Tumor size, n (%) | |
<20 mm | 89 (55%) |
20mm ≤ size < 50mm | 70 (43%) |
≥50mm | 4 (2%) |
Malignancy grade, n (%) | |
Grade 1 | 53 (32%) |
Grade 2 | 58 (36%) |
Grade 3 | 49 (30%) |
Not graded | 3 (2%) |
Estrogen receptor status, n (%) | |
Positive | 142 (87%) |
Negative | 21 (13%) |
HER2 status, n (%) | |
Normal expression | 126 (77%) |
Overexpression | 15 (9%) |
Unknown | 22 (14%) |
Axillary lymph node status, n (%) | |
Lymph node positive | 96 (59%) |
Lymph node negative | 67 (41%) |